Home » Stocks » Codexis

Codexis, Inc. (CDXS)

Stock Price: $13.42 USD 0.05 (0.37%)
Updated Aug 13, 2020 3:59 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 793.48M
Revenue (ttm) 70.19M
Net Income (ttm) -14.29M
Shares Out 59.13M
EPS (ttm) -0.24
PE Ratio n/a
Forward PE 138.89
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 13, 2020
Last Price $13.42
Previous Close $13.37
Change ($) 0.05
Change (%) 0.37%
Day's Open 13.41
Day's Range 13.26 - 13.55
Day's Volume 153,299
52-Week Range 8.43 - 18.87

More Stats

Market Cap 793.48M
Enterprise Value 742.30M
Earnings Date (est) Nov 10, 2020
Ex-Dividend Date n/a
Shares Outstanding 59.13M
Float 43.40M
EPS (basic) -0.24
EPS (diluted) -0.24
FCF / Share -0.34
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 5.16M
Short Ratio 12.66
Short % of Float 7.97%
Beta 0.63
PE Ratio n/a
Forward PE 138.89
P/FCF Ratio n/a
PS Ratio 11.30
PB Ratio 8.25
Revenue 70.19M
Operating Income -14.62M
Net Income -14.29M
Free Cash Flow -20.11M
Net Cash 51.18M
Net Cash / Share 0.87
Gross Margin 27.00%
Operating Margin -20.83%
Profit Margin -20.40%
FCF Margin -28.65%
ROA -6.33%
ROE -14.77%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (6)

Buy 6
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$18.83*
(40.31% upside)
Low
15.0
Current: $13.42
High
23.0
Target: 18.83
*Average 12-month price target from 6 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue68.4660.5950.0248.8441.8035.3131.9288.30124107
Revenue Growth12.98%21.13%2.43%16.82%18.4%10.6%-63.85%-28.71%15.65%-
Gross Profit52.8347.9735.7039.0835.2225.5817.3757.6582.0879.12
Operating Income-12.55-11.30-22.97-8.56-7.94-19.35-41.45-30.84-15.91-7.12
Net Income-11.94-10.88-23.00-8.56-7.58-19.07-41.30-30.86-16.55-8.54
Shares Outstanding56.5352.2146.2340.6339.4438.2138.2336.7735.6724.59
Earnings Per Share-0.21-0.21-0.50-0.21-0.19-0.50-1.08-0.84-0.46-0.35
Operating Cash Flow-12.56-14.09-8.76-1.86-0.430.32-23.00-11.89-0.49-16.38
Capital Expenditures-3.73-2.77-0.98-0.85-1.18-0.14-0.94-2.93-10.74-6.98
Free Cash Flow-16.29-16.86-9.74-2.71-1.610.19-23.94-14.83-11.23-23.36
Cash & Equivalents92.2254.4932.7820.8624.0627.2025.8547.0454.9973.86
Total Debt26.120.060.30-------
Net Cash / Debt66.1054.4232.4720.8624.0627.2025.8547.0454.9973.86
Assets14979.2853.6335.6544.6548.1258.8499.97136141
Liabilities43.5622.9829.0816.5521.7721.8117.3621.5333.2333.94
Book Value10656.3124.5519.1022.8826.3141.4878.44103107
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Codexis, Inc.
Country United States
Employees 161
CEO John J. Nicols

Stock Information

Ticker Symbol CDXS
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: CDXS
IPO Date April 22, 2010

Description

Codexis, Inc. discovers, develops, and sells protein catalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering protein catalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.